13-162
Showing 1 - 25 of 6,277
Vaccine Responsiveness in Chronic Lymphocytic Leukemia
Active, not recruiting
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- PCV13 vaccine and any of the FDA-approved COVID-19 vaccine products (BNT162b2, mRNA-1273, or Ad26.COV2.S) based on local availability.
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Sep 20, 2021
Meningitis, Meningococcal Trial in Worldwide (MenACYW conjugate vaccine, MMR, Varicella)
Completed
- Meningitis, Meningococcal
- MenACYW conjugate vaccine
- +4 more
-
Ansan, Korea, Republic of
- +36 more
Mar 24, 2022
Diabetes, Type 2 Trial in Shinjuku-ku, Hachioji, Yokohama (LY3209590, Insulin Degludec)
Completed
- Diabetes Mellitus, Type 2
- LY3209590
- Insulin Degludec
-
Shinjuku-ku, Jp-13, Japan
- +2 more
Dec 2, 2020
Platelet Aggregation, Type 2 Diabetes, Aspirin Trial in Montréal (Aspirin 81Mg Ec Tab twice daily for 7 days, Aspirin 40Mg Chew
Not yet recruiting
- Platelet Aggregation
- +4 more
- Aspirin 81Mg Ec Tab twice daily for 7 days
- +2 more
-
Montréal, Quebec, CanadaMontreal Heart Institute
Jan 25, 2023
Healthy Volunteers Trial in Baltimore, Springfield (ASA, non-enteric-coated chewable aspirin)
Recruiting
- Healthy Volunteers
- ASA
- non-enteric-coated chewable aspirin
-
Baltimore, Maryland
- +1 more
Nov 21, 2022
Hypoxia Trial in Ankara (Normobaric Hypoxia Exposure, Normobaric Normoxia Exposure)
Completed
- Hypoxia
- Normobaric Hypoxia Exposure
- Normobaric Normoxia Exposure
-
Ankara, TurkeyAnkara University
Jul 22, 2023
Gastrointestinal Stromal Tumor (GIST) Trial in New York (drug, other, procedure)
Active, not recruiting
- Gastrointestinal Stromal Tumor (GIST)
- MEK162
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 28, 2022
Complicated Urinary Tract Infection, Acute Pyelonephritis Trial in Worldwide (TBPM-PI-HBr, Ertapenem, Dummy Infusion)
Completed
- Complicated Urinary Tract Infection
- Acute Pyelonephritis
- TBPM-PI-HBr
- +3 more
-
La Mesa, California
- +95 more
Jun 27, 2022
Systemic Sclerosis, Scleroderma Trial in Worldwide (Anifrolumab (blinded), Placebo (blinded), Anifrolumab (unblinded, open
Not yet recruiting
- Systemic Sclerosis
- Scleroderma
- Anifrolumab (blinded)
- +2 more
-
Birmingham, Alabama
- +130 more
Jun 22, 2023
Severe Acute Respiratory Syndrome Trial in Worldwide (Otilimab, Placebo 1, Placebo 2)
Completed
- Severe Acute Respiratory Syndrome
- Otilimab
- +3 more
-
Mobile, Alabama
- +119 more
Mar 22, 2022
Finasteride and Male Breast Cancer - A Register-Based Nested
Completed
- Male Breast Cancer
- (no location specified)
Feb 7, 2022
Seasonal Allergic Rhinitis Trial (Comparator: montelukast, Comparator: loratadine, Comparator: )
Completed
- Seasonal Allergic Rhinitis
- Comparator: montelukast
- +3 more
- (no location specified)
Feb 7, 2022
ASA 81 mg vs 162 mg During Frozen Embryo Transfer (FET)
Active, not recruiting
- Fertility Disorders
- Frozen embryo transfer
-
Montreal, Quebec, CanadaClinique Ovo
Nov 7, 2023
SARS-CoV-2 Infection, COVID-19 Trial in Australia, New Zealand (BNT162b2, Placebo, Seasonal Inactivated Influenza Vaccine)
Completed
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
- +2 more
-
Brookvale, New South Wales, Australia
- +25 more
Nov 22, 2023
Squamous Cell Carcinoma of the Anal Canal Trial in Worldwide (carboplatin, paclitaxel, retifanlimab)
Recruiting
- Squamous Cell Carcinoma of the Anal Canal
- carboplatin
- +2 more
-
Tucson, Arizona
- +85 more
Jun 13, 2022
Chronic Hepatitis B Trial in Melbourne (162, Placebo)
Recruiting
- Chronic Hepatitis B
- 162
- Placebo
-
Melbourne, AustraliaNucleus Network Pty Ltd
Jun 5, 2022
SARS-CoV-2 Infection, COVID-19 Trial in Australia, New Zealand (BNT162b2, Placebo, Seasonal Inactivated Influenza Vaccine)
Completed
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
- +2 more
-
Brookvale, New South Wales, Australia
- +25 more
Nov 13, 2023
Nicotine Dependence, Cigarettes Trial in Burlington (Nicotine Corrective Messages)
Completed
- Nicotine Dependence, Cigarettes
- Nicotine Corrective Messages
-
Burlington, VermontUniversity of Vermont
Nov 15, 2022
Parkinson's Disease, Levodopa Induced Dyskinesias (LID) Trial in Worldwide (240mg Amantadine HCl ER tablets, Placebo tablets,
Terminated
- Parkinson's Disease
- Levodopa Induced Dyskinesias (LID)
- 240mg Amantadine HCl ER tablets
- +2 more
-
Tucson, Arizona
- +55 more
Feb 14, 2022
Dry Eye Disease Trial in United States (CyclASol topical ocular, eye drops, Vehicle topical ocular, eye drops)
Completed
- Dry Eye Disease
- CyclASol topical ocular, eye drops
- Vehicle topical ocular, eye drops
-
Newport Beach, California
- +8 more
Dec 21, 2022
Limb-Girdle Muscular Dystrophy Trial in Worldwide (Deflazacort)
Terminated
- Limb-Girdle Muscular Dystrophy
-
Atlanta, Georgia
- +17 more
May 31, 2022